EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo

Nirmal Kumar, Irshad Maajid Taily, Charandeep Singh, Sahil Kumar, Raju S Rajmani, Debajyoti Chakraborty, Anshul Sharma, Priyanka Singh, Krishan Gopal Thakur, Raghavan Varadarajan, Rajesh P Ringe, Prabal Banerjee und 1 weitere

PLOS Pathogens · 2023

DOI: 10.1371/journal.ppat.1011358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2023. Verfasst von Nirmal Kumar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Virology Lab, Department of Biological Sciences, Indian Institute of Science Education and Research, Mohali (IISER Mohali), Mohali, India. Hauptthemen laut MEDLINE: Influenza A virus, COVID-19. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Board of Research in Nuclear Sciences, Department of Atomic Energy, India, Science & Engineering Research Board, Department of Science and Technology, India, Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A virus (IAV) poses enormous challenge in the development of broad-spectrum antivirals that are effective against the existing and emerging viral strains. Virus entry through endocytosis represents an attractive target for drug development, as inhibition of this early infection step should block downstream infection processes, and potentially inhibit viruses sharing the same entry route. In this study, we report the identification of 1,3-diphenylurea (DPU) derivatives (DPUDs) as a new class of endocytosis inhibitors, which broadly restricted entry and replication of several SARS-CoV-2 and IAV strains. Importantly, the DPUDs did not induce any significant cytotoxicity at concentrations effective against the viral infections. Examining the uptake of cargoes specific to different endocytic pathways, we found that DPUDs majorly affected clathrin-mediated endocytosis, which both SARS-CoV-2 and IAV utilize for cellular entry. In the DPUD-treated cells, although virus binding on the cell surface was unaffected, internalization of both the viruses was drastically reduced. Since compounds similar to the DPUDs were previously reported to transport anions including chloride (Cl - ) across lipid membrane and since intracellular Cl - concentration plays a critical role in regulating vesicular trafficking, we hypothesized that the observed defect in endocytosis by the DPUDs could be due to altered Cl - gradient across the cell membrane. Using in vitro assays we demonstrated that the DPUDs transported Cl - into the cell and led to intracellular Cl - accumulation, which possibly affected the endocytic machinery by perturbing intracellular Cl - homeostasis. Finally, we tested the DPUDs in mice challenged with IAV and mouse-adapted SARS-CoV-2 (MA 10). Treatment of the infected mice with the DPUDs led to remarkable body weight recovery, improved survival and significantly reduced lung viral load, highlighting their potential for development as broad-spectrum antivirals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza A virusCOVID-19AnimalsMiceSARS-CoV-2EndocytosisVirus InternalizationAntiviral Agents

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Cellular Virology Lab, Department of Biological Sciences, Indian Institute of Science Education and Research, Mohali (IISER Mohali), Mohali, India.
  • Department of Chemistry, Indian Institute of Technology Ropar (IIT Ropar), Rupnagar, Punjab, India.
  • Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR-IMTECH), Chandigarh, India.
  • Molecular Biophysics Unit, Indian Institute of Science, Bangalore (IISc), Bengaluru, India.

ORCID-Profile: Indranil Banerjee

Förderung

  • Board of Research in Nuclear Sciences, Department of Atomic Energy, India
  • Science & Engineering Research Board, Department of Science and Technology, India
  • Bill and Melinda Gates Foundation

Zitieren

APA

Kumar, N., Taily, I. M., Singh, C., Kumar, S., Rajmani, R. S., Chakraborty, D., Sharma, A., Singh, P., Thakur, K. G., Varadarajan, R., Ringe, R. P., Banerjee, P., & Banerjee, I. (2023). Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011358

Vancouver

Kumar N, Taily IM, Singh C, Kumar S, Rajmani RS, Chakraborty D, et al. Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo. PLOS Pathogens. 2023. doi:10.1371/journal.ppat.1011358

BibTeX
@article{Kumar2023,
  author = {Kumar, Nirmal and Taily, Irshad Maajid and Singh, Charandeep and Kumar, Sahil and Rajmani, Raju S and Chakraborty, Debajyoti and Sharma, Anshul and Singh, Priyanka and Thakur, Krishan Gopal and Varadarajan, Raghavan and Ringe, Rajesh P and Banerjee, Prabal and Banerjee, Indranil},
  title = {Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo},
  journal = {PLOS Pathogens},
  year = {2023},
  doi = {10.1371/journal.ppat.1011358}
}
Kostenlos starten →